Biotech Values

[Dr Bill]

RE rfk1862/RPRX - I'm a little more exhuberant than that!

You're only looking for slightly more than double, on the high side?

Look at AMAG- went from 10-65 in just over a year, and doesn't have nearly the potential of this blockbuster.

There is currently not one good answer to women suffering with Fibroids. Ditto Endometriosis. Sales are easily 1.5 B worldwide. Give it a small multiple of 5 and divide by 12.8 Million shares and add in 60 Million dollars to boot - my previous example of europe androxal being worth an upfront cash of 30 million plus 30 million from the offering.

Plus phizer bayer etc pipelines, are all hurting right now, and probably are taking a very strong look at this one.